NEW YORK (GenomeWeb) – Verge Genomics, a startup developing machine learning technologies to apply genomics to drug discovery in neuroscience, said today that it has closed a $32 million Series A funding round.

Silicon Valley investment firm DFJ led the round, with participation from the WuXi AppTec's Corporate Venture Fund, the ALS Investment Fund, Agent Capital, and the OS Fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.